| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HC3701.095952 |
| P698 | PubMed publication ID | 11560853 |
| P2093 | author name string | Elliott PM | |
| McKenna WJ | |||
| Davies MJ | |||
| Baboonian C | |||
| Davison F | |||
| Varnava AM | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypertrophic cardiomyopathy | Q1364270 |
| P304 | page(s) | 1380-1384 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease | |
| P478 | volume | 104 |
| Q41687674 | A One Health Approach to Hypertrophic Cardiomyopathy |
| Q54345908 | A low prevalence of MYH7/MYBPC3 mutations among familial hypertrophic cardiomyopathy patients in India. |
| Q38028220 | A potential role for integrin signaling in mechanoelectrical feedback |
| Q33161569 | A primer on arrhythmias in patients with hypertrophic cardiomyopathy |
| Q46413646 | A window to the heart: can zebrafish mutants help us understand heart disease in humans? |
| Q37413343 | Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations |
| Q28570951 | Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy |
| Q52725150 | Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models. |
| Q34275552 | American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro |
| Q36824519 | Analysis of the molecular pathogenesis of cardiomyopathy-causing cTnT mutants I79N, ΔE96, and ΔK210. |
| Q37410985 | Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation |
| Q35115012 | Association of noninvasively measured left ventricular mechanics with in vitro muscle contractile performance: a prospective study in hypertrophic cardiomyopathy patients. |
| Q36826251 | Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass |
| Q28187589 | Autopsy findings in siblings with hypertrophic cardiomyopathy caused by Arg92Trp mutation in the cardiac troponin T gene showing dilated cardiomyopathy-like features |
| Q46049216 | Cardiac troponin T is essential in sarcomere assembly and cardiac contractility |
| Q21328674 | Cardiac troponin mutations and restrictive cardiomyopathy |
| Q38724869 | Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility |
| Q34388932 | Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice |
| Q90533953 | Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy |
| Q48177445 | Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals |
| Q46135637 | Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy |
| Q35771997 | Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis |
| Q37372239 | Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T Mutations |
| Q92543202 | Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy |
| Q79299051 | Different Coronary Blood Flow Increase in Left Ventricular Hypertrophy Due to Hypertension Compared to Hypertrophic Cardiomyopathy at Elevated Heart Rate |
| Q33764571 | Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy |
| Q51730904 | Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers. |
| Q37652430 | Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy |
| Q84448571 | Effect of heterogeneities in the cellular microstructure on propagation of the cardiac action potential |
| Q34188103 | Effects of two familial hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin |
| Q37255253 | Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all |
| Q35063399 | Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach |
| Q21129229 | Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused review |
| Q63440935 | Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy |
| Q37125766 | Genetic determinants of cardiac hypertrophy |
| Q38125385 | Genetic testing for inherited cardiac disease |
| Q38169914 | Genetics of sudden cardiac death caused by ventricular arrhythmias |
| Q40526444 | Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy |
| Q35762855 | Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations |
| Q42515078 | Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy |
| Q42339402 | Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment |
| Q50022359 | Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes. |
| Q35087752 | Hypertrophic cardiomyopathy: from gene defect to clinical disease |
| Q37070209 | Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression |
| Q92225133 | Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias |
| Q24292763 | Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations |
| Q36371337 | Impact of Mendelian inheritance in cardiovascular disease |
| Q37054964 | Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere |
| Q37680390 | Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility. |
| Q37415192 | Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice |
| Q38046158 | Insights and challenges in hypertrophic cardiomyopathy, 2012. |
| Q79372098 | Is sudden cardiac death predictable in LEOPARD syndrome? |
| Q39099962 | L71F mutation in rat cardiac troponin T augments crossbridge recruitment and detachment dynamics against α-myosin heavy chain, but not against β-myosin heavy chain |
| Q28235380 | Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression |
| Q37949516 | Mechanisms of disease: hypertrophic cardiomyopathy |
| Q34641881 | Modifier genes for hypertrophic cardiomyopathy |
| Q37675919 | Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond |
| Q34021080 | Molecular genetics and pathogenesis of hypertrophic cardiomyopathy |
| Q39038606 | Murine Electrophysiological Models of Cardiac Arrhythmogenesis |
| Q37816783 | Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy. |
| Q28264798 | Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? |
| Q36593277 | Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies |
| Q41896456 | Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia. |
| Q30484558 | Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. |
| Q49957679 | Myofilament Calcium-Buffering Dependent Action Potential Triangulation in Human-Induced Pluripotent Stem Cell Model of Hypertrophic Cardiomyopathy |
| Q34474908 | Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy |
| Q35880670 | Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. |
| Q93174381 | Pathogenic troponin T mutants with opposing effects on myofilament Ca2+ sensitivity attenuate cardiomyopathy phenotypes in mice |
| Q88564292 | Postmortem cardiac magnetic resonance in sudden cardiac death |
| Q47886356 | Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective |
| Q37445574 | Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems |
| Q41698138 | Right ventricle myectomy |
| Q34195775 | Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia |
| Q80482543 | Sudden Cardiac Death |
| Q36242912 | Surgical correction of hypertrophic obstructive cardiomyopathy in a patient with severe hypertrophy and septal myocardial fibrosis |
| Q73429825 | Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy. A study of 204 cases (1996-2000) |
| Q37738593 | Taxonomy of segmental myocardial systolic dysfunction |
| Q41997993 | The effect of cardiomyopathy mutation (R97L) in mouse cardiac troponin T on the muscle length-mediated recruitment of crossbridges is modified divergently by α- and β-myosin heavy chain |
| Q37636605 | The genetics of cardiomyopathy: genotyping and genetic counseling |
| Q37034674 | The mystery of sudden death: mechanisms for risks |
| Q37239549 | The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy |
| Q28307606 | Thin filament mutations: developing an integrative approach to a complex disorder |
| Q38520406 | Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. |
| Q30245043 | Update on hypertrophic cardiomyopathy and a guide to the guidelines. |
| Q83568905 | [Clinical and genetic aspects of hypertrophic and dilated cardiomyopathy] |
| Q79748186 | [What is late gadolinium enhancement in hypertrophic cardiomyopathy?] |
Search more.